Attenuated traumatic axonal injury and improved functional outcome after traumatic brain injury in mice lacking Sarm1. 2016

Nils Henninger, and James Bouley, and Elif M Sikoglu, and Jiyan An, and Constance M Moore, and Jean A King, and Robert Bowser, and Marc R Freeman, and Robert H Brown
1 Department of Neurology, University of Massachusetts Medical School, Worcester, MA 01655, USA 2 Department of Psychiatry University of Massachusetts Medical School, Worcester, MA 01655, USA nils.henninger@umassmed.edu.

Axonal degeneration is a critical, early event in many acute and chronic neurological disorders. It has been consistently observed after traumatic brain injury, but whether axon degeneration is a driver of traumatic brain injury remains unclear. Molecular pathways underlying the pathology of traumatic brain injury have not been defined, and there is no efficacious treatment for traumatic brain injury. Here we show that mice lacking the mouse Toll receptor adaptor Sarm1 (sterile α/Armadillo/Toll-Interleukin receptor homology domain protein) gene, a key mediator of Wallerian degeneration, demonstrate multiple improved traumatic brain injury-associated phenotypes after injury in a closed-head mild traumatic brain injury model. Sarm1(-/-) mice developed fewer β-amyloid precursor protein aggregates in axons of the corpus callosum after traumatic brain injury as compared to Sarm1(+/+) mice. Furthermore, mice lacking Sarm1 had reduced plasma concentrations of the phophorylated axonal neurofilament subunit H, indicating that axonal integrity is maintained after traumatic brain injury. Strikingly, whereas wild-type mice exibited a number of behavioural deficits after traumatic brain injury, we observed a strong, early preservation of neurological function in Sarm1(-/-) animals. Finally, using in vivo proton magnetic resonance spectroscopy we found tissue signatures consistent with substantially preserved neuronal energy metabolism in Sarm1(-/-) mice compared to controls immediately following traumatic brain injury. Our results indicate that the SARM1-mediated prodegenerative pathway promotes pathogenesis in traumatic brain injury and suggest that anti-SARM1 therapeutics are a viable approach for preserving neurological function after traumatic brain injury.

UI MeSH Term Description Entries
D008297 Male Males
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D001930 Brain Injuries Acute and chronic (see also BRAIN INJURIES, CHRONIC) injuries to the brain, including the cerebral hemispheres, CEREBELLUM, and BRAIN STEM. Clinical manifestations depend on the nature of injury. Diffuse trauma to the brain is frequently associated with DIFFUSE AXONAL INJURY or COMA, POST-TRAUMATIC. Localized injuries may be associated with NEUROBEHAVIORAL MANIFESTATIONS; HEMIPARESIS, or other focal neurologic deficits. Brain Lacerations,Acute Brain Injuries,Brain Injuries, Acute,Brain Injuries, Focal,Focal Brain Injuries,Injuries, Acute Brain,Injuries, Brain,Acute Brain Injury,Brain Injury,Brain Injury, Acute,Brain Injury, Focal,Brain Laceration,Focal Brain Injury,Injuries, Focal Brain,Injury, Acute Brain,Injury, Brain,Injury, Focal Brain,Laceration, Brain,Lacerations, Brain
D003337 Corpus Callosum Broad plate of dense myelinated fibers that reciprocally interconnect regions of the cortex in all lobes with corresponding regions of the opposite hemisphere. The corpus callosum is located deep in the longitudinal fissure. Interhemispheric Commissure,Neocortical Commissure,Callosum, Corpus,Callosums, Corpus,Commissure, Interhemispheric,Commissure, Neocortical,Commissures, Interhemispheric,Commissures, Neocortical,Corpus Callosums,Interhemispheric Commissures,Neocortical Commissures
D003598 Cytoskeletal Proteins Major constituent of the cytoskeleton found in the cytoplasm of eukaryotic cells. They form a flexible framework for the cell, provide attachment points for organelles and formed bodies, and make communication between parts of the cell possible. Proteins, Cytoskeletal
D005260 Female Females
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001369 Axons Nerve fibers that are capable of rapidly conducting impulses away from the neuron cell body. Axon
D014855 Wallerian Degeneration Degeneration of distal aspects of a nerve axon following injury to the cell body or proximal portion of the axon. The process is characterized by fragmentation of the axon and its MYELIN SHEATH. Degeneration, Wallerian
D016229 Amyloid beta-Peptides Peptides generated from AMYLOID BETA-PEPTIDES PRECURSOR. An amyloid fibrillar form of these peptides is the major component of amyloid plaques found in individuals with Alzheimer's disease and in aged individuals with trisomy 21 (DOWN SYNDROME). The peptide is found predominantly in the nervous system, but there have been reports of its presence in non-neural tissue. Alzheimer beta-Protein,Amyloid Protein A4,Amyloid beta-Peptide,Amyloid beta-Protein,beta Amyloid,beta-Amyloid Protein,Alzheimer's ABP,Alzheimer's Amyloid Fibril Protein,Amyloid AD-AP,Amyloid Fibril Protein, Alzheimer's,Amyloid beta-Proteins,ABP, Alzheimer's,AD-AP, Amyloid,Alzheimer ABP,Alzheimer beta Protein,Alzheimers ABP,Amyloid AD AP,Amyloid beta Peptide,Amyloid beta Peptides,Amyloid beta Protein,Amyloid beta Proteins,Amyloid, beta,Protein A4, Amyloid,Protein, beta-Amyloid,beta Amyloid Protein,beta-Peptide, Amyloid,beta-Peptides, Amyloid,beta-Protein, Alzheimer,beta-Protein, Amyloid,beta-Proteins, Amyloid

Related Publications

Nils Henninger, and James Bouley, and Elif M Sikoglu, and Jiyan An, and Constance M Moore, and Jean A King, and Robert Bowser, and Marc R Freeman, and Robert H Brown
September 1999, No to hattatsu = Brain and development,
Nils Henninger, and James Bouley, and Elif M Sikoglu, and Jiyan An, and Constance M Moore, and Jean A King, and Robert Bowser, and Marc R Freeman, and Robert H Brown
November 2012, Journal of neurotrauma,
Nils Henninger, and James Bouley, and Elif M Sikoglu, and Jiyan An, and Constance M Moore, and Jean A King, and Robert Bowser, and Marc R Freeman, and Robert H Brown
June 1997, Brain injury,
Nils Henninger, and James Bouley, and Elif M Sikoglu, and Jiyan An, and Constance M Moore, and Jean A King, and Robert Bowser, and Marc R Freeman, and Robert H Brown
February 2013, Neuroscience,
Nils Henninger, and James Bouley, and Elif M Sikoglu, and Jiyan An, and Constance M Moore, and Jean A King, and Robert Bowser, and Marc R Freeman, and Robert H Brown
December 1995, Archives of physical medicine and rehabilitation,
Nils Henninger, and James Bouley, and Elif M Sikoglu, and Jiyan An, and Constance M Moore, and Jean A King, and Robert Bowser, and Marc R Freeman, and Robert H Brown
September 2008, Journal of neurosurgery,
Nils Henninger, and James Bouley, and Elif M Sikoglu, and Jiyan An, and Constance M Moore, and Jean A King, and Robert Bowser, and Marc R Freeman, and Robert H Brown
May 2008, Archives of physical medicine and rehabilitation,
Nils Henninger, and James Bouley, and Elif M Sikoglu, and Jiyan An, and Constance M Moore, and Jean A King, and Robert Bowser, and Marc R Freeman, and Robert H Brown
February 2020, Acta neurologica Scandinavica,
Nils Henninger, and James Bouley, and Elif M Sikoglu, and Jiyan An, and Constance M Moore, and Jean A King, and Robert Bowser, and Marc R Freeman, and Robert H Brown
January 2021, Surgical neurology international,
Nils Henninger, and James Bouley, and Elif M Sikoglu, and Jiyan An, and Constance M Moore, and Jean A King, and Robert Bowser, and Marc R Freeman, and Robert H Brown
January 2019, Nutrients,
Copied contents to your clipboard!